Kyung Nam Pharm Co.,Ltd. Stock: price and insider trades · South Korea

This page follows insider dealings at Kyung Nam Pharm Co.,Ltd. as filed with DART (FSS), a company from the Health Care sector. The last twelve months, up to 2 November 2026, brought 10 filings signed by 3 insiders.

On the market, 2 insiders bought (4 purchases) while 2 insiders sold (4 sales). No amount is published for 8 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 1 major shareholder.

The last insider purchase was made public on 3 July 2026, 129 days ago. Typically, a trade is published a median of 7 days after it takes place. This delay matters because a trade only becomes useful information once it is public.

With 10 filings in twelve months, the company is more active than the median of 7 filings across the 2,655 companies we follow on the same exchange. Since 2021, the database holds 15 purchases and 24 sales by insiders of the company.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.